Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -7.00 is 100% above its 5-year average of -6532.68, near the high end of its 5-year range (-20400.00–-7.00).
87.46% above its 12-month average of -55.82.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.87.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 15 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T19:33:11.019Z. Historical observations retain their original dates. Historical series through 2024-05-10.
EARNINGS PER SHARE (EPS)
-7.00
EARNINGS PER SHARE (EPS) AVG TTM
-55.82
EARNINGS PER SHARE (EPS) AVG 3Y
-2440.85
EARNINGS PER SHARE (EPS) AVG 5Y
-6532.68
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+87.46%
CURRENT VS 3Y AVG
+99.71%
CURRENT VS 5Y AVG
+99.89%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Revelation Biosciences, Inc.
Market Cap
$2.94M
Earnings Per Share (EPS)
-7.00
TTM Avg
-55.82
3Y Avg
-2440.85
5Y Avg
-6532.68
Market Cap
$3.02M
Earnings Per Share (EPS)
-1.43
TTM Avg
-2.52
3Y Avg
-2.09
5Y Avg
-1.32
Market Cap
$3.14M
Earnings Per Share (EPS)
-22.20
TTM Avg
-27.40
3Y Avg
-44.30
5Y Avg
-249.07
Market Cap
$2.75M
Earnings Per Share (EPS)
N/A
TTM Avg
-1245.93
3Y Avg
-1251.86
5Y Avg
-260.76
Market Cap
$3.15M
Earnings Per Share (EPS)
-6.76
TTM Avg
-8.05
3Y Avg
-9.85
5Y Avg
-9.67
Market Cap
$2.72M
Earnings Per Share (EPS)
-50.28
TTM Avg
-397.20
3Y Avg
-675.82
5Y Avg
-681.84
Market Cap
$3.17M
Earnings Per Share (EPS)
N/A
TTM Avg
-12.74
3Y Avg
-17.52
5Y Avg
-18.26
Market Cap
$3.23M
Earnings Per Share (EPS)
-11.70
TTM Avg
-48.19
3Y Avg
-238.41
5Y Avg
-340.02
Market Cap
$2.60M
Earnings Per Share (EPS)
-132.69
TTM Avg
-152.69
3Y Avg
-28794.02
5Y Avg
-195833.20
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Revelation Biosciences, Inc. (REVB) | $2.94M | -7.00 | -55.82 | -2440.85 | -6532.68 |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.02M | -1.43 | -2.52 | -2.09 | -1.32 |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.14M | -22.20 | -27.40 | -44.30 | -249.07 |
| Universe Pharmaceuticals Inc. (UPC)vs › | $2.75M | N/A | -1245.93 | -1251.86 | -260.76 |
| IceCure Medical Ltd (ICCM)vs › | $3.15M | -6.76 | -8.05 | -9.85 | -9.67 |
| iSpecimen Inc. (ISPC)vs › | $2.72M | -50.28 | -397.20 | -675.82 | -681.84 |
| MBody AI Ltd. (MBAI)vs › | $3.17M | N/A | -12.74 | -17.52 | -18.26 |
| Aethlon Medical, Inc. (AEMD)vs › | $3.23M | -11.70 | -48.19 | -238.41 | -340.02 |
| Nuwellis, Inc. (NUWE)vs › | $2.60M | -132.69 | -152.69 | -28794.02 | -195833.20 |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.32M | N/A | -1108.98 | -1045.55 | -1171.01 |
Trailing EPS (TTM)
$-7.00
Forward EPS (Est.)
$-5.18
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -23.95 |
| 2024-12-31 | -87.68 |
| 2023-12-31 | -8.41 |
| 2022-12-31 | -9643.37 |
| 2021-12-31 | -20400.00 |
| 2020-12-31 | -9032.69 |
| 2019-12-31 | -6.72 |
